You can find the annual or quarterly income statement of Pelthos Therapeutics Ord Shs here for insights into the performance and operational efficiency of Pelthos Therapeutics Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

Total revenue

--9.39M

--7.41M

Revenue

--9.39M

--7.41M

Cost of revenue

--2.55M

--3.00M

Operating expenses

--21.39M

--22.77M

R&D expenses

--374.00K

--145.00K

Depreciation, depletion, and amortization

--1.22M

--1.07M

Other operating expenses

---5.46M

----

Operating profit

---12.00M

---15.36M

Net non-operating interest income (expenses)

Non-operating interest expense

--1.31M

--1.35M

Special income (expenses)

---15.27M

----

Other non-operating income (expenses)

--0.00

--5.00K

Income before tax

---28.59M

---16.70M

Income tax

---6.92M

---465.00K

Income after tax

---21.66M

---16.24M

Net income from continuous operations

---21.66M

---16.24M

Net income attributable to controlling interests

---21.66M

---16.24M

Net income attributable to common shareholders

---21.66M

---16.24M

Basic earnings per share

---6.81

---5.30

Diluted earnings per share

---6.81

---5.30

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

